Table 1.
SERT inhibition | 5HT2C antagonism | NET inhibition |
DAT inhibition | σ1 agonist |
M1 antagonism | NOS inhibition | H1-antagonist | 5HT1A agonist | 5HT1B partial agonist |
5HT1D antagonist |
5HT3 antagonist | 5HT7 antagonist | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citalopram | + | + | |||||||||||
Escitalopram | + | ||||||||||||
Fluoxetine | + | + | + (only at very high doses) | ||||||||||
Fluvoxamine | + | + | |||||||||||
Paroxetine | + | + | + | + | |||||||||
Sertraline | + | + | + | ||||||||||
Venlafaxine | + | + | |||||||||||
Vortioxetine | + | + | + | + | + | + |
SERT serotonin transporter, 5-HT 5-hydroxytryptamine, DAT dopamine transporter, H1 histamine 1 receptor, M1 muscarinic acetylcholine 1 receptor, NET norepinephrine transporter, NOS nitric oxide synthetase, SERT serotonin transporter, DAT dopamine transporter, σ1 sigma 1 receptor, M1 muscarinic acetylcholine 1 receptor, NOS nitric oxide synthetase, H1 histamine 1 receptor, σ1 sigma 1 receptor